SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-000672
Filing Date
2019-01-04
Accepted
2019-01-04 16:30:28
Documents
29
Period of Report
2019-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv510270_8k.htm 8-K 20367
2 EXHIBIT 99.1 tv510270_ex99-1.htm EX-99.1 31788
3 GRAPHIC image_001.jpg GRAPHIC 34578
4 GRAPHIC image_002.jpg GRAPHIC 158645
5 GRAPHIC image_003.jpg GRAPHIC 101052
6 GRAPHIC image_004.jpg GRAPHIC 62149
7 GRAPHIC image_005.jpg GRAPHIC 54902
8 GRAPHIC image_006.jpg GRAPHIC 124545
9 GRAPHIC image_007.jpg GRAPHIC 94101
10 GRAPHIC image_008.jpg GRAPHIC 74336
11 GRAPHIC image_009.jpg GRAPHIC 87453
12 GRAPHIC image_010.jpg GRAPHIC 98492
13 GRAPHIC image_011.jpg GRAPHIC 119918
14 GRAPHIC image_012.jpg GRAPHIC 120707
15 GRAPHIC image_013.jpg GRAPHIC 73479
16 GRAPHIC image_014.jpg GRAPHIC 95087
17 GRAPHIC image_015.jpg GRAPHIC 94551
18 GRAPHIC image_016.jpg GRAPHIC 90656
19 GRAPHIC image_017.jpg GRAPHIC 59992
20 GRAPHIC image_018.jpg GRAPHIC 122080
21 GRAPHIC image_019.jpg GRAPHIC 106575
22 GRAPHIC image_020.jpg GRAPHIC 96016
23 GRAPHIC image_021.jpg GRAPHIC 105501
24 GRAPHIC image_022.jpg GRAPHIC 49211
25 GRAPHIC image_023.jpg GRAPHIC 116895
26 GRAPHIC image_024.jpg GRAPHIC 101020
27 GRAPHIC image_025.jpg GRAPHIC 77703
28 GRAPHIC image_026.jpg GRAPHIC 120425
29 GRAPHIC image_027.jpg GRAPHIC 61356
  Complete submission text file 0001144204-19-000672.txt   3496594
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 19510480
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1